Patent details

EP2134322 Title: INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING BLADDER CANCER

Basic Information

Publication number:
EP2134322
PCT Application Number:
US2008056912
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087321626
PCT Publication Number:
WO2008112934
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING BLADDER CANCER
French Title of Invention:
ADMINISTRATION INTRAVÉSICALE D'APAZIQUONE APRÈS RÉSECTION TRANSURÉTHRALE POUR TRAITER LE CANCER DE LA VESSIE
German Title of Invention:
INTRAVESIKALE VERABREICHUNG VON APAZICHON NACH TRANSURETHRALER RESEKTION ZUR BEHANDLUNG VON BLASENKREBS
SPC Number:

Dates

Filing date:
13/03/2008
Grant date:
20/02/2019
EP Publication Date:
23/12/2009
PCT Publication Date:
18/09/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/02/2019
EP B1 Publication Date:
20/02/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/03/2019
Expiration date:
13/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/02/2019
 
 

Name:
Spectrum Pharmaceuticals, Inc.
Address:
157 Technology Drive, Irvine, CA 92618, United States (US)

Inventor

1

Name:
BEER, Mario
Address:
United States (US)

2

Name:
LENAZ, Luigi
Address:
United States (US)

3

Name:
CHAWLA, Shanta
Address:
United States (US)

Priority

Priority Number:
894610 P
Priority Date:
13/03/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/19; A61K 31/404; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
201908
Publication date:
20/02/2019
Description:
Grant (B1)

2

Issue number:
201913
Publication date:
27/03/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages